LLY stock

Eli Lilly (LLY) Stock After Hours on December 8, 2025: China Mounjaro Win, Dividend Hike and What to Watch Before Tuesday’s Open

Eli Lilly and Company (NYSE: LLY) spent Monday, December 8, 2025, digesting a wave of news: a major reimbursement win for Mounjaro in China, a 15% dividend hike, new leukemia drug data, and the return of Nobel laureate Carolyn Bertozzi

9 December 2025

Eli Lilly (LLY) Stock on 6 December 2025: Zepbound Price Cuts, $1 Trillion Milestone and 2026 Forecasts

Eli Lilly and Company (NYSE: LLY) heads into the final weeks of 2025 as one of the most closely watched stocks on Wall Street – and not just in healthcare. After briefly crossing the $1 trillion market-cap mark in November

6 December 2025

Company News · Financial Forecasts · Investment Analysis · NYSE:LLY · Pharmaceuticals · Stock Market

Eli Lilly (LLY) Stock on December 1, 2025: Zepbound Price Cuts, $1 Trillion Milestone and 2026 Outlook

As of December 1, 2025, Eli Lilly and Company (NYSE: LLY) is trading around $1,075 per share, giving the drugmaker a market capitalization of roughly $1.0–1.02 trillion and cementing its status as the first pharmaceutical company to enter the trillion‑dollar

1 December 2025

Company Analysis · Financial Forecasts · Investment · NYSE:LLY · Pharma News · Stock Market

Eli Lilly (LLY) Stock Today, November 28, 2025: Post–$1 Trillion Milestone, Is the Rally Catching Its Breath?

On Friday, November 28, 2025, Eli Lilly and Company (NYSE: LLY) shares traded lower, giving back a slice of recent gains after the drugmaker became the first pharmaceutical company ever to hit a $1 trillion market valuation on November 21.

28 November 2025

Eli Lilly · Financial News · Investing · Market Analysis · NYSE:LLY · Stock Market

Eli Lilly (LLY) Stock Today, November 23, 2025: Trillion‑Dollar Milestone, GLP‑1 Price War and Fresh Institutional Buying

Eli Lilly’s stock is entering the new week as one of the most closely watched names on Wall Street. As of this weekend (Sunday, November 23, 2025), LLY is trading near $1,060 per share, valuing the company at roughly $1

23 November 2025

Financial News · Investment Strategies · Market Analysis · Pharmaceutical Industry · Stock Market

Eli Lilly (LLY) Stock Soars on Weight-Loss Drug Boom – Can It Hit $1,000?

October Stock Moves and Market Reaction Eli Lilly’s stock has moved sharply in recent weeks. After languishing around the mid-$700s in late September, the stock soared in early October. Between Sept. 29 and Oct. 1 it jumped over 9%, briefly

30 October 2025

Investing · Market Analysis · NYSE:LLY · Pharmaceuticals · Stocks · Weight Loss